RVL Pharmaceuticals

RVL Pharmaceuticals Net Margin

The Net Profit Margin of RVL Pharmaceuticals (RVLPQ) as of Nov 16, 2026 is -103.96 %. In the previous year, Net Profit Margin was -473.40 % — a change of -78.04% (higher).

Net Margin

-103.96 %

YoY

-78.04%

Last updated:

Net Profit Margin of RVL Pharmaceuticals is 2022 -103.96 % . Net Profit Margin of RVL Pharmaceuticals was 2021 -473.40 % . It decreases by -78.04% higher compared to the previous year.

For RVL Pharmaceuticals, the net margin of -104.0% is down versus -41.6% a few years ago.

The RVL Pharmaceuticals Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2016
-19.14 USD
Jan 1, 2017
-18.37 USD
Jan 1, 2018
-41.59 USD
Jan 1, 2019
-112.86 USD
Jan 1, 2020
-320.63 USD
Jan 1, 2021
-473.40 USD
Jan 1, 2022
-103.96 USD
The RVL Pharmaceuticals Net Margin history
YEARNet MarginYoY
-103.96 %-78.04%
-473.40 %+47.65%
-320.63 %+184.09%
-112.86 %+171.35%
-41.59 %+126.36%
-18.37 %-4.02%
-19.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RVL Pharmaceuticals Stock analysis

What does RVL Pharmaceuticals do? Osmotica Pharmaceuticals PLC is a global pharmaceutical company based in Dublin, Ireland. It was founded in 2008 and focuses on the development and marketing of specialized pharmaceutical products for the treatment of neurological and psychiatric disorders, as well as behavioral disorders. The company is divided into three business segments: the Commercial Part, the Branded Part, and the Trident Part. The Commercial Part is responsible for marketing generic pharmaceuticals and other specialty products in the USA and Canada. This includes products such as Venlafaxine ER for the treatment of depression and the Parkinson's medication Apomorphine. The Branded Part is responsible for the development and marketing of its own products. This includes products such as Osmolex ER for the treatment of Parkinson's and akathisia, as well as Ontinua ER for the treatment of fibromyalgia and neuropathies. The Trident Part of the company focuses on the development of novel ophthalmology products and other specialty products for the global market. The company has a strong commitment to clinical research and development, particularly in the development of new products for use in neurology and psychiatry. Osmotica holds a number of patents for its products and has a range of products in various stages of clinical development. The success of Osmotica is based on its business model, which relies on ongoing innovation through research and development, as well as a strong distribution network for its products. Thanks to its broad product portfolio and global presence, the company is well positioned for further growth and the expansion into new markets in the future. Overall, Osmotica Pharmaceuticals PLC is an emerging pharmaceutical company with a strong focus on the development of specialized products for neurological and psychiatric disorders, as well as behavioral disorders. The company has a broad product portfolio and is well positioned for future growth. RVL Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RVL Pharmaceuticals stock

Net Profit Margin of RVL Pharmaceuticals is -103.96 % in 2022.

Net Profit Margin of RVL Pharmaceuticals changed from -473.40 % to -103.96 %, representing a -78.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin RVL Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's RVL Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RVL Pharmaceuticals

All Key Metrics — RVL Pharmaceuticals